NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells

Journal of Immunology

Volumn 160, Issue 2, 1998, Pages 674-680

  Kung, Sam K P ^a   Su, Ruey Chyi ^a   Graham, Jeremy J K ^b   Chamberlain, John W ^b   Miller, Richard G ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN;

ANIMAL CELL; ARTICLE; CELL HYBRIDIZATION; CELL KILLING; GENETIC RESISTANCE; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SPLEEN CELL;

ANIMALS; CELL LINE; CONCANAVALIN A; CROSSES, GENETIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDES;

EID: 0031985623     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kiessling, R., G. Petranyi, G. Klein, and H. Wigzell. 1975. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semisyngeneic mice against a mouse lymphoma line. Int. J. Cancer 15:933.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
3. Murphy, W. J., V. Kumar, and M. Bennett. 1987. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID): evidence that natural killer cells can mediate the specificity of marrow graft rejection. J. Exp. Med. 165:1212.
4. Haller, O., R. Kiessling, A. Orn, K. Karre, K. Nilsson, and H. Wigzell. 1977. Natural cytotoxicity to human leukemia mediated by mouse non-T cells. Int. J. Cancer 20:93.
5. Raulet, D. H., and W. Held. 1995. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell 82:697.
6. Lanier, L. L., and J. H. Phillips. 1996. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17:86.
7. Yokoyama, W. M. 1995. Right-side-up and up-side-down NK cell receptors. Curr. Biol. 5:982.
8. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675.
9. + IL-2-activated natural killer cells. Nature 358: 66.
10. Chan, P.-Y., and F. Takei. 1989. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48. J. Immunol. 143:1379.
11. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingari, and L. Moretta. 1996. Receptors for HLA class I molecules in human natural killer cells. Anna. Rev. Immunol. 14:619.
12. Wagtman, N., R. Biassoni, C. Cantoni, S. Verdiani, M. S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E. O. Long. 1995. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439.
13. Bennett, M. 1987. Biology and genetics of hybrid resistance. Adv. Immunol. 41:333.
14. Cudkowicz, G. 1971. Genetic control of bone marrow graft rejection. I. Determinant-specific difference of reactivity in two pairs of inbred mouse strains. J. Exp. Med. 134:281.
15. Cudkowicz, G., and M. Bennet. 1971. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J. Exp. Med. 134:83.
16. Kiessling, R., P. S. Hochman, O. Haller, G. M. Shearer, H. Wizgell, and G. Cudkowicz. 1977. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur. J. Immunol. 7:655.
17. Chadwick, B. S., and R. G. Miller. 1992. Hybrid resistance in vitro: possible role of both class I MHC and self-peptides in determining the level of target cell sensitivity. J. Immunol. 148:2307.
18. Moretta, L., E. Ciccone, A. Moretta, P. Hoglund, C. Ohlen, and K. Karre. 1992. Allorecognition by NK cells: nonself or no self?. Immunol. Today 13:300.
19. Sentman, C. L., J. Hackett Jr., V. Kumar, and M. Bennett. 1989. Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J. Exp. Med. 170:191.
20. Yu, Y. Y. L., J. R. George, J. R. Dorfman, J. Roland, V. Kumar, and M. Bennett. 1996. The role of Ly49A and 5E6 (Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4:67.
21. Kung, S. K. P., and R. G. Miller. 1997. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. J. Immunol. 155:2616.
22. Hoglund, P., R. Glas, C. Ohlen, H. G. Ljunggren, and K. Karre. 1991. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target. J. Exp. Med. 174:327.
23. Storkus, W. J., J. Alexander, J. A. Payne, P. Cresswell, and J. R. Dawson. 1989. The α1/α2 domains of class I HLA molecules confer resistance to natural killing. J. Immunol. 143:3853.
24. Storkus, W. J., R. D. Salter, J. Alexander, F. E. Ward, R. E. Ruiz, P. Cresswell, and J. R. Dawson. 1991. Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc. Natl. Acad. Sci. USA 88:5989.
25. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016.
26. Correa, I., and D. H. Raulet. 1995. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells. Immunity 2:61.
27. Chadwick, B. S., S. R. Sambhara, Y. Sasakura, and R. G. Miller. 1992. Effect of class I MHC binding peptides on recognition by natural killer cells. J. Immunol. 149:3150.
28. Chamberlain, J. W., J. A. Nolan, P. J. Conrad, H. A. Vasavada, H. H. Vasavada, S. Ganguly, C. A. Janeway Jr., and S. M. Weissman. 1988. Tissue-specific and cell surface expression of human major histocompatibility complex class I heavy (HLA-B7) and light (beta2-microglobulin) chain genes in transgenic mice. Proc. Natl. Acad. Sci. USA 85:7690.
29. Sheng-Tanner, X., and R. G. Miller. 1992. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. J. Exp. Med. 176: 407.
30. Goding, J. W. 1986. Monoclonal Antibodies: Principles and Practice. Academic Press, New York.
31. 1 antiparent killing in vitro. J. Immunol. 154:1624.
32. Karasuyama, H., N. Tohyama, and T. Tada. 1989. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J. Exp. Med. 169:13.
33. Jardetzky, T. S., W. S. Lane, R. A. Robinson, D. R. Madden, and D. C. Wiley. 1991. Identification of self peptides bound to purified HLA-B27. Nature 353:326.
34. Rotzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H-G. Rammensee. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252.
35. Sambhara, S. R., A. G. Upadhya, and R. G. Miller. 1990. Generation and characterization of peptide-specific. MHC-restricted cytotoxic T lymphocyte (CTL) and helper T cell lines from unprimed T cells under microculture conditions. J. Immunol. Methods 130:101.
36. Rotzschke, O., K. Falk, S. Stevanovie, G. Jung, P. Waiden, and H-G. Rammensee. 1991. Exact prediction of a actural T cell epitope. Eur. J. Immunol. 21:289.
37. Sentman, C. L., M. Y. Olsson, M. Salcedo, P. Hoglund, U. Lendahl, and K. Kare. 1994. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets: protection mediated by α1/α2 domains. J. Immunol. 153: 5482.
38. Storkus, W. J., D. N. Howell, R. D. Salter, J. R. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138:1657.
39. Storkus, W. J., R. D. Salter, P. Cresswell, and J. R. Dawson. 1992. Peptide-induced modulation of target cell sensitivity to natural killing. J. Immunol. 149: 1185.
40. Olsson, M. Y., K. Karre, and C. L. Sentman. 1995. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc. Natl. Acad. Sci. USA 92: 1649.